CHMP issues positive opinion to expand Jardiance®, Synjardy® and Glyxambi® labels to include positive effects on cardiovascular and renal outcomes
INGELHEIM, Germany & INDIANAPOLIS–(BUSINESS WIRE)– European labels for Jardiance®, Synjardy® and Glyxambi® expanded to include positive effects on cardiovascular and renal endpoints from landmark EMPA-REG...